Impact of Glaucoma and Visual Field Loss on Life Space
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
2 other identifiers
observational
88
1 country
1
Brief Summary
Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptualized as a continuum from bed bound (immobility) on one extreme to making excursions to distant locations on the other extreme. Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy that can lead to gradual loss of vision in the peripheral field and central vision. Older adults with POAG have an increased risk for motor vehicle collisions and falls. Moreover, existing studies suggest that patients with POAG exhibit more postural sway while standing as measured by a balance platform and also tend to walk more slowly than those who are normally sighted and free of ocular disease. While these disturbances likely influence mobility, there has been little research directly assessing the impact of POAG on mobility. This study will assess the impact of POAG on life space (one aspect of mobility) and will determine whether difficulties with life space are associated with difficulties experienced under conditions of dim lighting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2018
CompletedFirst Posted
Study publicly available on registry
September 17, 2018
CompletedStudy Start
First participant enrolled
October 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedSeptember 11, 2025
September 1, 2025
8 months
September 11, 2018
September 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of life space measured with the Life Space Questionnaire
The Life Space Questionnaire is a 9-item questionnaire that assesses how much a person gets out and about and the spatial extent of the person's typical life space, i.e., what is the usual range of places in which the person engages in activities within the designated time frame. Patients are asked to respond either Yes or No.
Day one
Secondary Outcomes (4)
Relationship between the Life Space Questionnaire and vision loss
Day one
Assessment of vision under dim illumination and at night using the Low Luminance Questionnaire
Day one
Relationship between Low Luminance Questionnaire and vision loss
Day one
Relationship between the Low Luminance Questionnaire and the Life Space Questionnaire
Day one
Study Arms (1)
Primary Open-Angle Glaucoma
Two following two questionnaires will be administered: 1. Life Space Questionnaire: This 9-item questionnaire is interested in finding out how much a person gets out and about and the spatial extent of the person's typical life space, i.e., what is the usual range of places in which the person engages in activities within the designated time frame. 2. Low Luminance Questionnaire: This 32-item questionnaire is interested in finding out problems that involve vision under different lighting conditions or feelings that people have about your vision under different lighting conditions.
Interventions
Two questionnaires will be administered, one focusing on life space and the other focusing on low luminance.
Eligibility Criteria
Participants that are enrolled in the Early Detection of Glaucoma Progression using a Novel Individualized Approach (IRB-300000301) or in the African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the Lamina Cribrosa in Progression (IRB-161115004).
You may qualify if:
- Clinical diagnosis of primary open-angle glaucoma
- Best-corrected visual acuity of 20/40 or better
- Spherical refraction within ± 5 Diopters
- Cylinder refraction within ± 3 Diopters
You may not qualify if:
- History of intra-ocular surgery other than uncomplicated cataract or glaucoma surgery
- Significant cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lyne Racette, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 11, 2018
First Posted
September 17, 2018
Study Start
October 9, 2018
Primary Completion
May 30, 2019
Study Completion (Estimated)
May 30, 2026
Last Updated
September 11, 2025
Record last verified: 2025-09